Profiling the chemical differences of diterpenoid alkaloids in different processed products of Aconiti Lateralis Radix Praeparata by UHPLC-LTQ-Orbitrap mass spectrometry combined with untargeted metabolomics and mass spectrometry imaging

Abstract

Aconiti Lateralis Radix Praeparata (Fuzi) represents a significant traditional Chinese medicine (TCM) that exhibits both notable pharmacological effects and toxicity. Various processing methods are implemented to reduce the toxicity of raw Fuzi by modifying its toxic and effective components, primarily diterpenoid alkaloids. To comprehensively analyze the chemical variations between different Fuzi products, ultra-high performance liquid chromatography-linear ion trap quadrupole Orbitrap mass spectrometry (UHPLC-LTQ-Orbitrap MS) was employed to systematically characterize Shengfuzi, Heishunpian and Baifupian. A total of 249 diterpenoid alkaloids present in Shengfuzi were identified, while only 111 and 61 in Heishunpian and Baifupian were detected respectively, indicating substantial differences among these products. An untargeted metabolomics approach combined with multivariate statistical analysis revealed 42 potential chemical markers. Through subsequent validation using 52 batches of commercial Heishunpian and Baifupian samples, 8 robust markers distinguishing these products were identified, including AC1-propanoic acid-3OH, HE-glucoside, HE-hydroxyvaleric acid-2OH, dihydrosphingosine, N-dodecoxycarbonylvaline and three unknown compounds. Additionally, the MS imaging (MSI) technique was utilized to visualize the spatial distribution of chemical constituents in raw Fuzi, revealing how different processing procedures affect the chemical variations between Heishunpian and Baifupian. The distribution patterns of different diterpenoid alkaloid subtypes partially explained the chemical differences among products. This research provides valuable insights into the material basis for future investigations of different Fuzi products.

Keywords

Aconiti Lateralis Radix Praeparata / Diterpenoid alkaloids / Processing / Untargeted metabolomics / Mass spectrometry imaging

References

[1] Pharmacopoeia of the Peoples Republic of China. Beijing: People’s Medical Publishing House. 2020;1:200-201.

[2] Zhou GH, Tang LY, Zhou XD, et al. A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux. J Ethnopharmacol. 2015; 160:173-193. https://doi.org/10.1016/j.jep.2014.11.043.

[3] Wang M, Hu WJ, Zhou X, et al. Ethnopharmacological use, pharmacology toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii Debeaux. (Fuzi): a review. J Ethnopharmacol. 2023;301:115838. https://doi.org/10.1016/j.jep.2022.115838.

[4] Singhuber J, Zhu M, Prinz S, et al. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol. 2009; 126:18-30. https://doi.org/10.1016/j.jep.2009.07.031.

[5] Liu S, Li F, Li Y, et al. A review of traditional and current methods used to potentially reduce toxicity of Aconitum roots in traditional Chinese medicine. J Ethnopharmacol. 2017; 207:237-250. https://doi.org/10.1016/j.jep.2017.06.038.

[6] Wu JJ, Guo ZZ, Zhu YF, et al. A systematic review of pharmacokinetic studies on herbal drug Fuzi: implications for Fuzi as personalized medicine. Phytomedicine. 2018; 44:187-203. https://doi.org/10.1016/j.phymed.2018.03.001.

[7] Yu Y, Wu SF, Zhang JQ, et al. Structurally diverse diterpenoid alkaloids from the lateral roots of Aconitum carmichaelii Debx. and their anti-tumor activities based on in vitro systematic evaluation and network pharmacology analysis. RSC Adv. 2021; 11:26594-26606. https://doi.org/10.1039/D1RA04223H.

[8] Liu M, Cao Y, Lv DY, et al. Effect of processing on the alkaloids in Aconitum tubers by HPLC-TOF/MS. J Pharm Anal. 2017; 7:170-175. https://doi.org/10.1016/j.jpha.2017.01.001.

[9] Wang Y, Shi L, Song F, et al. Exploring the ester-exchange reactions of diester-diterpenoid alkaloids in the Aconite Decoction process by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Sp. 2003; 17(4):279-284. https://doi.org/10.1002/rcm.914.

[10] Yu Y, Yao CL, Zhang JQ, et al. Comprehensive quality evaluation of Aconiti Lateralis Radix Praeparata based on pseudotargeted metabolomics and simultaneous determination of fifteen components, and development of new processed products of black slices with less toxicity. J Pharmaceut Biomed Anal. 2023;228:115295. https://doi.org/10.1016/j.jpba.2023.115295.

[11] Yu Y, Yao CL, Guo DA. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry. Acta Pharm Sin B. 2021; 11(6):1469-1492. https://doi.org/10.1016/j.apsb.2021.02.017.

[12] Yu Y, Yao CL, Wei WL, et al. Integration of offline two-dimensional chromatography and mass defect filtering-based precursor ion list data acquisition for targeted characterization of diterpenoid alkaloids in the lateral roots of Aconitum carmichaelii. J Chromatogr A. 2022;1684:463554. https://doi.org/10.1016/j.chroma.2022.463554.

[13] Buchberger AR, DeLaney K, Johnson J, et al. Mass spectrometry imaging: a review of emerging advancements and future insights. Anal Chem. 2018; 90(1):240-265. https://doi.org/10.1021/acs.analchem.7b04733.

[14] Hou JJ, Zhang ZJ, Wu WY, et al. Mass spectrometry imaging: new eyes on natural products for drug research and development. Acta Pharmacol Sin. 2022; 43:3096-3111. https://doi.org/10.1038/s41401-022-00990-8.

[15] Liu Y, Yang XX, Zhou C, et al. Unveiling dynamic changes of chemical constituents in raw and processed Fuzi with different steaming time points using desorption electrospray ionization mass spectrometry imaging combined with metabolomics. Front Pharmacol. 2022;13:842890. https://doi.org/10.3389/fphar.2022.842890.

[16] Li CY, Sha MX, Pei ZQ, et al. Dynamic variations in the chemical constituents of Tiebangchui stir-fried with Zanba by integrating UPLC-Q-TOF-MS based metabolomics and DESI-MSI. Arab J Chem. 2023;16:104957. https://doi.org/10.1016/j.arabjc.2023.104957.

[17] Pu TT, Liu J, Zhou ZY, et al. Differences between processed product Heishunpian and Baifupian using fourier transform infrared spectroscopy and HPLC. Chin Tradit Herbal Drugs. 2024; 55(2):596-604. https://doi.org/10.7501/j.issn.0253-2670.2024.02.025.

[18] Nesterova YV, Povet'yeva TN, Suslov NI, et al. Analgesic activity of diterpene alkaloids from Aconitum baikalensis. Bull Exp Biol Med. 2014; 157(4):488-491. https://doi.org/10.1007/s10517-014-2598-6.

[19] Shao F, Li SL, Liu RH, et al. Analgesic and anti-inflammatory effects of different processed products of Aconiti Lateralis Radix Praeparata. Lishizhen Med Mater Med Res. 2011; 22(10):2329-2330. https://doi.org/10.1111/j.1600-0714.2011.01024.x.

[20] Xie XF, Peng C, Yi JH, et al. Comparative study on acute toxicity of extracts from different processed products of Aconiti Lateralis Radix Praeparata. Pharm Clin Chin Mater Med. 2012; 3(3):29-33,51.

[21] Dong YH, Li B, Malitsky S, et al. Sample preparation for mass spectrometry imaging of plant tissues: a review. Front Plant Sci. 2016; 7:1-16. https://doi.org/10.3389/fpls.2016.00060.